Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, April 17, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
Gerard van Odijk |
|
|
2. |
Reason for the notification |
||
|
a) |
Position/status |
Chairman of the Board of Bavarian Nordic A/S |
|
|
b) |
Initial notification/Amendment |
Initial notification |
|
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Bavarian Nordic A/S |
|
|
b) |
LEI |
2138006JCDVYIN6INP51 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Shares
|
|
|
b) |
Nature of the transaction |
Acquisition of shares (vesting of restricted stock units) |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
|
DKK 138.43 |
2,709 |
|
d) |
Aggregated information - Aggregated volume - Price |
2,709 DKK 375,000.00 |
|
|
e) |
Date of the transaction |
2021-04-17 |
|
|
f) |
Place of the transaction |
Outside a trading venue |
|
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
Anders Gersel Pedersen |
|
|
2. |
Reason for the notification |
||
|
a) |
Position/status |
Deputy Chairman of the Board of Bavarian Nordic A/S |
|
|
b) |
Initial notification/Amendment |
Initial notification |
|
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Bavarian Nordic A/S |
|
|
b) |
LEI |
2138006JCDVYIN6INP51 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Shares
|
|
|
b) |
Nature of the transaction |
Acquisition of shares (vesting of restricted stock units) |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
|
DKK 138.46 |
1,625 |
|
d) |
Aggregated information - Aggregated volume - Price |
1,625 DKK 225,000.00 |
|
|
e) |
Date of the transaction |
2021-04-17 |
|
|
f) |
Place of the transaction |
Outside a trading venue |
|
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
Erik G. Hansen |
|
|
2. |
Reason for the notification |
||
|
a) |
Position/status |
Member of the Board of Bavarian Nordic A/S |
|
|
b) |
Initial notification/Amendment |
Initial notification |
|
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Bavarian Nordic A/S |
|
|
b) |
LEI |
2138006JCDVYIN6INP51 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Shares
|
|
|
b) |
Nature of the transaction |
Acquisition of shares (vesting of restricted stock units) |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
|
DKK 138.50 |
1,083 |
|
d) |
Aggregated information - Aggregated volume - Price |
1,083 DKK 150,000.00 |
|
|
e) |
Date of the transaction |
2021-04-17 |
|
|
f) |
Place of the transaction |
Outside a trading venue |
|
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
Frank Verwiel |
|
|
2. |
Reason for the notification |
||
|
a) |
Position/status |
Member of the Board of Bavarian Nordic A/S |
|
|
b) |
Initial notification/Amendment |
Initial notification |
|
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Bavarian Nordic A/S |
|
|
b) |
LEI |
2138006JCDVYIN6INP51 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Shares
|
|
|
b) |
Nature of the transaction |
Acquisition of shares (vesting of restricted stock units) |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
|
DKK 138.50 |
1,083 |
|
d) |
Aggregated information - Aggregated volume - Price |
1,083 DKK 150,000.00 |
|
|
e) |
Date of the transaction |
2021-04-17 |
|
|
f) |
Place of the transaction |
Outside a trading venue |
|
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
Elizabeth McKee Anderson |
|
|
2. |
Reason for the notification |
||
|
a) |
Position/status |
Member of the Board of Bavarian Nordic A/S |
|
|
b) |
Initial notification/Amendment |
Initial notification |
|
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Bavarian Nordic A/S |
|
|
b) |
LEI |
2138006JCDVYIN6INP51 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Shares
|
|
|
b) |
Nature of the transaction |
Acquisition of shares (vesting of restricted stock units) |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
|
DKK 138.50 |
1,083 |
|
d) |
Aggregated information - Aggregated volume - Price |
1,083 DKK 150,000.00 |
|
|
e) |
Date of the transaction |
2021-04-17 |
|
|
f) |
Place of the transaction |
Outside a trading venue |
|
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
Peter Kürstein |
|
|
2. |
Reason for the notification |
||
|
a) |
Position/status |
Member of the Board of Bavarian Nordic A/S |
|
|
b) |
Initial notification/Amendment |
Initial notification |
|
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Bavarian Nordic A/S |
|
|
b) |
LEI |
2138006JCDVYIN6INP51 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Shares
|
|
|
b) |
Nature of the transaction |
Acquisition of shares (vesting of restricted stock units) |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
|
DKK 138.50 |
1,083 |
|
d) |
Aggregated information - Aggregated volume - Price |
1,083 DKK 150,000.00 |
|
|
e) |
Date of the transaction |
2021-04-17 |
|
|
f) |
Place of the transaction |
Outside a trading venue |
|
About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacture and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Strategic National Stockpile of a non-replicating smallpox vaccine, which has been approved by the FDA under the trade name JYNNEOS®, also for the protection against monkeypox. The vaccine is approved as a smallpox vaccine in Europe under the trade name IMVANEX® and in Canada under the trade name IMVAMUNE®. Our commercial product portfolio furthermore contains the market-leading vaccine Rabipur®/RabAvert® against rabies and Encepur® against tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, MVABEA®, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccine based on an in-licensed capsid virus-like particle technology. The vaccine candidate, ABNCoV2, is currently being investigated in clinical trials. For more information visit www.bavarian-nordic.com.
Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600
Company Announcement no. 15 / 2021